Watchlists Portfolios Alerts Pricing Sign in Get started

Menu

Surrozen, Inc. SRZN

Full chart Compare

Set alert

31.88 USD -0.76 (-2.33%)

At closeNov 11, 2026, 4:00 PM EST

31.88 0.00 0.00%

After hours · Nov 11, 4:00 PM ET

31.69 Day range 33.74

12.12 52-week range 37.83

YTD: +41.06%
1 year: +163.04%

News

1 day ago benzinga.com Cantor Fitzgerald Maintains Overweight on Surrozen, Raises Price Target to $62 Cantor Fitzgerald analyst Steve Seedhouse maintains Surrozen (NASDAQ:SRZN) with a Overweight and raises the price target from $40 to $62.
2 days ago globenewswire.com Surrozen Reports Third Quarter 2026 Financial Results and Provides Business Update First patient dosed in Phase 1b of DUET study evaluating SZN-8141 in patients with diabetic macular edema DUET Phase 2a enrollment to be expanded from approximately 60 to 150 patients to enable a…
5 days ago globenewswire.com Surrozen to Present at Upcoming Healthcare Investor Conference SOUTH SAN FRANCISCO, Calif., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics to harness the…